Nektar Therapeutics reported $-125162000 in Pre-Tax Profit for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US $ -82.79M 8.09M
Baxter International BAX:US $ 501M 39M
Biogen BIIB:US $ 814.2M 255M
Bluebird Bio BLUE:US $ -231.42M 25.67M
Cara Therapeutics CARA:US $ -30745000 7.44M
Dr.Reddys Laboratories DRRD:IN IR 7396M 771M
Eisai 4523:JP Y 55783M 61588M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Esperion Therapeutics ESPR:US $ -43668000 47.27M
Exelixis EXEL:US $ 124.89M 126.9M
Gilead Sciences GILD:US $ 2747M 464M
Halozyme Therapeutics HALO:US $ 91.52M 36.81M
Immunogen IMGN:US $ -30.74M 3.31M
IONIS PHARMACEUT IONS:US $ -81M 8.74M
Ironwood Pharmaceuticals IRWD:US $ 57.26M 18.98M
Karyopharm Therapeutics KPTI:US $ -53448000 3.82M
Macrogenics MGNX:US $ -39.94M 11.34M
Merk MRK:US $ 3892M 257M
Nektar Therapeutics NKTR:US $ -125.16M 3.89M
Neurocrine Biosciences NBIX:US $ 57.5M 30.3M
Novartis NOVN:VX SF 4424M 620M
Sarepta Therapeutics SRPT:US $ -81.76M 85.63M
Teva Pharmaceutical TEVA:IT 382M 412M
Xencor XNCR:US $ 52.25M 54.74M
YTE INCY:US $ 199.6M 31.06M